Discovery of the first-in-class potent and isoform-selective human carbonic anhydrase III inhibitors
Considering the unrecognised physio-pathological role of human carbonic anhydrase III (hCA III), a structure-based drug design was set up to identify the first-in-class potent and selective inhibitors of this neglected isoform. hCA III targeting was planned considering a unique feature of its active...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis Group
2023-12-01
|
| Edice: | Journal of Enzyme Inhibition and Medicinal Chemistry |
| Témata: | |
| On-line přístup: | https://www.tandfonline.com/doi/10.1080/14756366.2023.2202360 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
